Study highlights how fluorescence imaging benefits cervical and uterine cancer treatment
In recent years, the surgical technique sentinel lymph node biopsy has allowed surgeons to more accurately determine how far cancer has spread while lowering patient side effects.
It has become the standard of care in treating breast cancer, melanoma and vulvar cancers, and MD Anderson surgeons are leading clinical studies to apply the technique to treat other cancers, including cervical, uterine and head and neck cancers....
Improving B-cell lymphoma treatment with immunotherapies and more
Lymphomas are the most common hematological malignancy in the U.S., accounting for an estimated 80,000 new cancer diagnoses and 21,000 deaths...
Nobel Week kicks off for immunotherapy innovator Jim Allison
As his first official act of Nobel Week, 2018 Nobel Laureate in Physiology or Medicine Jim Allison, Ph.D., on Thursday signed the bottom of...
Be Well Baytown celebrates one year of making impact on community health
It is estimated that up to half of all cancers may be prevented by making healthy lifestyle choices. Cancer prevention and control is a cornerstone of MD Anderson’s mission to eliminate cancer.
Aligned with that mission, MD Anderson established Be Well Communities™, a place-based community approach for cancer prevention and control to promote wellness and reduce modifiable cancer risk factors. Launched in 2017, Be Well Communities...
Clinical trials lead to FDA approval of two drugs for acute myeloid leukemia
Researchers in MD Anderson’s Leukemia department played central roles in the studies of two drugs, glasdegib and venetoclax, approved in November...
Lung Cancer Moon Shot team is learning the most from patients
Despite a plethora of new and promising treatments available, lung cancer remains the leading cause of cancer death in the United States,...
Minimally invasive delivery of radiation therapy to pancreatic tumors
Pancreatic cancer is one of the most lethal types of cancer, expected to cause more than 44,000 deaths in the U.S. this year. It’s a deadly...
Next-generation sequencing bolsters breast, prostate and blood cancer research
MD Anderson’s Moon Shots Program™ was established to bring teams of world-class clinicians and researchers together in order to rapidly advance...
More cervical cancer recurrence with minimally invasive surgery
Minimally invasive hysterectomies, which are known for shorter, less stressful recovery periods, are considered easier on patients. But two...
ARTEMIS clinical trial offers triple-negative patients personalized therapy
Triple-negative breast cancer (TNBC) makes up 15 to 20 percent of breast cancer diagnoses. The condition often is considered a single disease...
Possible side effects of immunotherapy — and how to handle them
Over the past decade, immune checkpoint inhibitors have shown success in treating several types of cancer, including melanoma, non-small cell...
Biomarker predicts response to pancreatic cancer therapy
MD Anderson researchers have discovered that a protein called angiogenin (ANG) serves as a potential biomarker useful for stratifying pancreatic...
Potential biomarker linked to better outcomes in acute myeloid leukemia
Somatic mutations in certain genes may function as a molecular minimal residual disease marker for acute myeloid leukemia (AML), according...
Moon Shot update: Gaining ground on hard-to-treat blood cancers
Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) encompass a spectrum of diseases characterized by an overproduction of immature...
Ovarian Moon Shot team battles highly recurrent disease
September is Ovarian Cancer Awareness Month, an annual time to bring attention to the impact of the disease. This year, more than 22,000 women...
Immunotherapy can fire up a protein that disables a T cell attack
Lung cancer immunotherapy triggers a counterattack by a surface protein found on the tumors of some patients that stifles the immune system...
Collaboration yields comprehensive CAR T-cell therapy pediatric guidelines
Almost one year after the Food and Drug Administration (FDA) approval of chimeric antigen receptor (CAR) T-cell therapy for children with...
MD Anderson once again named No. 1 for cancer care
MD Anderson Cancer Center again has been ranked No. 1 for cancer care by U.S. News & World Report’s annual “Best Hospitals” survey...
Communication skills may help keep research trainees on the academic track
A well-trained research workforce is essential for addressing both current and future health challenges in the U.S. However, according to...
New venture will lead to new treatments for chemotherapy's side effects
MD Anderson Cancer Center and Accelerator Life Science Partners, a leading life science investment and management firm, have launched Magnolia...
Uncovering an enemy of lung cancer immunotherapy
MD Anderson researchers have uncovered a genetic condition that thwarts the most common immunotherapy used against lung cancer, opening new...
Basic science research could greatly improve cancer prevention efforts
Many are aware of the importance of cancer research for the discovery of new therapies and treatment options, but perhaps less well-known...
Drug prolongs survival for patients with deadly type of AML
A study led by MD Anderson found the investigational drug quizartinib prolongs overall survival for patients with a deadly form of acute myeloid...
Innovative study delivers genetic screening to your doorstep
When Elizabeth White started a new job as executive director of the Michigan Ovarian Cancer Alliance in 2017, she decided it...
Therapeutics Discovery drug impairs cancer cells’ growth and survival
A drug discovered and advanced by MD Anderson’s Institute for Applied Cancer Science (IACS) and the TRACTION platform inhibits a vital...
An update on the Prostate Cancer Moon Shot's efforts to improve outcomes, save lives
Excluding skin cancers, prostate cancer is the most commonly diagnosed cancer among men in the United States. According to the American Cancer...
Using hypnosedation instead of general anesthesia during some breast cancer surgeries
Most people think of hypnosis as a kind of party trick — a mischievous way to make somebody unconsciously do your bidding.
But...
Pioneering endogenous T-cell therapy for cancer treatments
Immunotherapy, which stimulates the patient’s own immune system to attack cancer, has shown promise in treating a variety of cancer types...
MD Anderson faculty members awarded at ASCO Annual Meeting
For their role in transforming cancer care, three MD Anderson faculty received the American Society of Clinical Oncology’s Special Awards...
Matching targeted therapies to gene mutations improves survival
Matching targeted therapies to tumor-specific gene mutations across tumor types improved survival in patients with advanced cancer, compared...
Drug may benefit urinary tract cancer patients
In recent years, five new immunotherapy drugs have been approved to treat patients diagnosed with urinary cancer. But the drugs, which held...
Could a pill replace chemotherapy for some patients?
In a small Phase II study of early-stage breast cancer patients with BRCA 1 and 2 mutations, researchers found that more than half of women...
Researcher found a way to analyze the DNA of individual cancer cells
Understanding evolution within cancer cells is a longtime interest for Nicholas Navin, Ph.D., an associate professor of Genetics and Bioinformatics...
PARP inhibitor shows benefit for small cell lung cancer patients
In a randomized, Phase II trial led by researchers at MD Anderson, adding the PARP inhibitor veliparib to a standard chemotherapy agent improved...
8 researchers join ranks of Sabin Family Fellows
Eight MD Anderson researchers have been selected as the newest class of Andrew Sabin Family Fellows. As part of the Andrew Sabin Family Fellowship...
Her discovery expanded our knowledge of cancer genetics
Shortly after arriving at MD Anderson in 1987 as a junior faculty member, Guillermina Lozano, Ph.D., attended several seminars hosted by the...
Partnerships to reduce young people’s exposure to UV radiation
Reducing the incidence of melanoma through primary and secondary prevention is among one of the shared goals and key partnership strategies...
Training dermatologists to detect melanoma at its earliest stages
Each May, Skin Cancer Awareness Month serves as a reminder of how individuals can work to lower their risk of skin cancer – the most common...
Making re-irradiation an option for recurrent head and neck cancer
Patients with recurrent or second primary head and neck cancer who previously received radiation therapy to the head and neck region – especially...
Honing in on why triple-negative breast cancer can survive chemo
Triple-negative breast cancer (TNBC) is an aggressive form of the disease that doesn’t rely on the hormones estrogen and progesterone or the...
Quit-smoking toolkit targets residents of public housing
By July 31, all U.S. Department of Housing and Urban Development (HUD) housing will be required to be smokefree, in accordance to rule put...
Vaccine exposes evasive colorectal cancer to an immune attack
Immunotherapy has taken hold as an effective treatment for a variety of advanced cancers, but so far, colorectal cancer has...
Immune helper cells appear to fuel pancreatic cancer development
Immune cells that rush to repair damage caused by inflammatory tissue are subverted to cancer-promoting allies by pancreas cells that feature...
Improving practice to eliminate high risk and prevent breast cancer
Fewer than 30% of the women in the U.S. with abnormal, benign lesions known as atypical hyperplasia (AH) and lobular carcinoma in situ (LCIS...
Assets and obstacles in the fight to prevent HPV-related cancers
Despite the availability of vaccines that could prevent the majority of cancers caused by the human papillomavirus (HPV), the incidence of...
Immunotherapy, liquid biopsy research among AACR highlights
“Driving Innovative Cancer Science to Patient Care” was the theme of the American Association for Cancer Research’s annual meeting, which...
Fidler honored for landmark findings on cancer metastasis
The American Association for Cancer Research (AACR) has selected Isaiah J. Fidler, D.V.M., Ph.D., professor of Cancer Biology, as recipient...
Removing melanoma's cloak of immune invisibility
Melanoma cells are able to evade cancer immunotherapy by using a specific protein to hide from immune system T cells out to seek and destroy...
Merging an MRI with a linear accelerator allows greater precision in cancer treatment
When people breathe, there’s movement inside their bodies.
Organs, tissues and even cancer patients’ tumors move around all the time...
MD Anderson's research, prevention and recruitment efforts bolstered by $22 million from CPRIT
MD Anderson was awarded $22.3 million from the Cancer Prevention and Research Institute of Texas (CPRIT), accounting for 30% of the $73.5...
Using integromics to better understand and treat colorectal cancer
MD Anderson’s Colorectal Cancer Moon Shot™ is committed to the prevention and early detection of the third most common cancer diagnosed in...
MD Anderson company to develop cell therapies for cancer
Cell-based immunotherapies such as chimeric antigen receptors (CAR T), T-cell receptor (TCR) engineered T cells, tumor-infiltrating lymphocytes...
Proton therapy may help breast cancer patients avoid cardiotoxicity
Radiation therapy to the whole breast or chest wall and the internal mammary lymph nodes can deliver a radiation dose to the heart that increases...
Obesity linked to longer survival in men with advanced melanoma
Obese patients with metastatic melanoma who are treated with targeted or immune therapies live significantly longer than those with a normal...
Smart bomb virus shows promise as a brain tumor immunotherapy
A cold virus engineered to attack the most common and deadly of brain tumors allowed 20% of patients with recurrent glioblastoma to live for...
Immunotherapy leader Jim Allison honored by BBVA and King Faisal foundations
Organizations in Spain and Saudi Arabia recognized the leadership of Jim Allison, Ph.D., MD Anderson chair of Immunology, in cultivating the...
Targeted therapies before and after surgery delay melanoma progression
A pair of targeted therapies given before and after surgery for melanoma produced at least a six-fold increase in time to progression compared...
Checkpoint blockade immunotherapy may potentially treat triple negative breast cancer
Triple-negative breast cancer (TNBC), a highly aggressive, relapse-prone disease that accounts for one-fourth of all breast cancers, could...
New study evaluates need for biopsies after breast cancer treatment
In an analysis of more than 120,000 women diagnosed with and treated for early-stage breast cancer, researchers from MD Anderson Cancer...
Small increase in medication may play a big part in helping smokers quit
Increasing the dosage of a prescription smoking cessation medication by 1 milligram a day – from 2 to 3 milligrams – more than doubled abstinence...
New developments in managing chemotherapy-induced neuropathy
Chemotherapy is a proven and effective method for treating many types of cancer, but up to 90% of patients who receive the treatment develop...
Do modern chemo drugs raise the risk of leukemia in some older patients?
Older patients with non-metastatic breast cancer who have been treated modern chemotherapy drugs have a greater risk of secondary acute myeloid...
MD Anderson surgeons pioneer organ-sparing therapy for esophageal cancer
Until recently, patients with esophageal cancer were treated with esophagectomy, or removal of the affected part of the esophagus and surrounding...
Study sheds light on why some early-stage breast cancers progress and others do not
A new genetic-based model developed by an MD Anderson research team may explain how a common form of early-stage breast cancer known as ductal...